Grassi I.; Nanni C.; Allegri V.; Morigi J.J.; Montini G.C.; Castellucci P.; Fanti S., The clinical use of PET with (11)C-acetate., «AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 2, pp. 33 - 47 [Scientific article]
Pettinato, C.; Monari, F.; Nanni, Cristina; Allegri, V.; Marcatili, S.; Civollani, S.; Cima, S.; Spezi, E.; Mazzarotto, R.; Fanti, Stefano, Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I., «THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 56, pp. 509 - 514 [Scientific article]
Palomar A; Nanni C; Castellucci P; Ambrosini V; Montini GC; Allegri V; Pettinato C; Al-Nahhas A; Soriano A; Grassetto G; Rubello D; Fanti S., Value of FDG PET/CT in Patients with Treated Ovarian Cancer and Raised CA125 Serum Levels., «MOLECULAR IMAGING AND BIOLOGY», 2012, 14, pp. 123 - 129 [Scientific article]
Marcelo Mamede, Paolo Castellucci, Francesco Ceci, Riccardo Schiavina, Stefano Boschi, Valentina Ambrosini, Chiara Fuccio, Annarita Ianniello, Rossella Ferrara, Stefano Fanti, 11C-Choline PET/CT in patients with biochemical relapse after radical prostatectomy and PSA levels < 0.5 ng/mL, in: Supplement, «THE JOURNAL OF NUCLEAR MEDICINE», 2012, pp. N/A - N/A (atti di: SNMMI Annual Meeting, Miami, 10 Giugno 2012) [Abstract]
Lopci E.; Piccardo A.; Nanni C.; Altrinetti V.; Garaventa A.; Pession A.; Cistaro A.; Chiti A.; Villavecchia G.; Fanti S., 18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MR., «CLINICAL NUCLEAR MEDICINE», 2012, 37, pp. 73 - 78 [Scientific article]
Nicolini S.; Ambrosini V.; Fantini L.; Fanti S., 68Ga DOTANOC PET/CT detects medullary thyroid cancer relapse at bone level., «CLINICAL NUCLEAR MEDICINE», 2012, 37, pp. 591 - 592 [Scientific article]
Ambrosini V.; Campana D.; Tomassetti P.; Fanti S., 68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39 Suppl 1., pp. 52 - 60 [Scientific article]
Zanoni L.; Lopci E.; Ambrosini V.; Boschi S.; Fanti S., Alveolar Rhabdomyosarcoma With Neuroendocrine Differentiation Detected by Ga-68 DOTA-NOC PET/CT: A Case Report., «CLINICAL NUCLEAR MEDICINE», 2011, 36(10), pp. 915 - 918 [Scientific article]
FUCCIO C;SCHIAVINA R.;CASTELLUCCI P;RUBELLO D;MARTORANA G;CELLI M;MALIZIA C;PROFITOS MB;MARZOLA MC;PETTINATO V;FANTI S, Androgen deprivation therapy influences the uptake of 11C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET/CT study., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2011, 38, pp. 1985 - 1989 [Scientific article]
Fanti S.; Farsad M.; Mansi L., Atlas of SPECT-CT, VERLAG BERLIN HEIDELBERG, Springer, 2011, pp. 288 . [Research monograph]
Di Marco M; Macchini M; Vecchiarelli S; Casadei R; Pezzilli R; Fanti S;
Zanoni L; Calculli L; Barbieri E; Santini D; DI Cicilia R; Brandi G; Biasco G., Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer:A literature review and report of two cases, «ONCOLOGY LETTERS», 2011, 2, pp. 195 - 200 [Scientific article]
Fuccio C.; Rubello D.; Castellucci P.; Marzola M.C.; Fanti S., Choline PET/CT for prostate cancer: Main clinical applications., «EUROPEAN JOURNAL OF RADIOLOGY», 2011, 80 (2), pp. e50 - e56 [Scientific article]
V. Ambrosini; S. Fanti, Clinical applications of PET/CT in oncology:Neuroendocrine tumour, in: Principlesand Practice ofPET/CT Part 2 A Technologist‘s Guide, VIENNA, European Association of Nuclear Medicine, 2011, pp. 102 - 107 [Chapter or essay]
Rufini V.; Treglia G.; Castaldi P.; Perotti G.; Calcagni M.L.; Corsello S.M.; Galli G.; Fanti S.; Giordano A., Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma., «NUCLEAR MEDICINE COMMUNICATIONS», 2011, 32(7), pp. 575 - 582 [Scientific article]
Cerci J.J.; Trindade E.; Buccheri V.; Fanti S; Coutinho A.M.; Zanoni L.; Linardi C.C.; Celli M.; Delbeke D.; Pracchia L.F.; Pitela F.A.; Soares J. Jr.; Zinzani P.L.; Meneghetti J.C., Consistency of FDG-PET Accuracy and Cost-Effectiveness in Initial Staging of Patients With Hodgkin Lymphoma Across Jurisdictions., «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2011, 11(4), pp. 314 - 320 [Scientific article]
